Category: Medicine

Acilab SP 100mg/325mg/15mg Tablet 1*10

No Rating Available

Acilab SP 100mg/325mg/15mg Tablet is a combination medicine used for the short-term relief of pain, inflammation, and swelling in conditions affecting the joints and muscles. It works by blocking chemical messengers in the brain responsible for pain, making it effective in conditions like rheumatoid arthritis and osteoarthritis. In addition to painkillers, this medicine contains Serratiopeptidase, an enzyme that promotes healing and speeds up recovery. By reducing swelling and inflammation, it helps improve mobility and overall comfort.

93.5 110 -15%
This Product Has Been Added To The Cart.
View Cart
SKU: Sku has not been defined.

Description

Marketer
Dolchem Pharmaceuticals Private Limited
Composition:

Aceclofenac (100mg) Paracetamol (325mg) Serratiopeptidase (15mg)

Description:

Acilab SP 100mg/325mg/15mg Tablet is a combination medicine used to relieve muscle, joint, and postoperative pain. It effectively reduces pain and inflammation in conditions such as rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis. The tablet should be taken as per the dose and duration prescribed by your doctor, preferably with food or milk to minimize stomach discomfort. Regular intake at the recommended times enhances its effectiveness, and it is important to continue taking it until advised otherwise by your doctor.

Common side effects of Acilab SP 100mg/325mg/15mg Tablet include nausea, vomiting, stomach pain, indigestion, heartburn, increased liver enzymes, dizziness, drowsiness, and diarrhea. If taken for long-term treatment, your doctor may monitor your kidney function, liver function, and blood component levels. Prolonged use can lead to serious complications such as stomach bleeding and kidney problems. This medicine is not recommended for use during pregnancy or breastfeeding.

Reviews

There are no reviews yet.

Be the first to review “Acilab SP 100mg/325mg/15mg Tablet 1*10”

Your email address will not be published. Required fields are marked *